{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044388192000.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa031633"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa031633"}},{"identifier":{"@type":"NAID","@value":"30022560115"}}],"dc:title":[{"@value":"Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044388192009","@type":"Researcher","foaf:name":[{"@value":"Geoffrey A. Block"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192001","@type":"Researcher","foaf:name":[{"@value":"Kevin J. Martin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191879","@type":"Researcher","foaf:name":[{"@value":"Angel L.M. de Francisco"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192006","@type":"Researcher","foaf:name":[{"@value":"Stewart A. Turner"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192010","@type":"Researcher","foaf:name":[{"@value":"Morrell M. Avram"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192011","@type":"Researcher","foaf:name":[{"@value":"Michael G. Suranyi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191875","@type":"Researcher","foaf:name":[{"@value":"Gavril Hercz"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192129","@type":"Researcher","foaf:name":[{"@value":"John Cunningham"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191878","@type":"Researcher","foaf:name":[{"@value":"Ali K. Abu-Alfa"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192003","@type":"Researcher","foaf:name":[{"@value":"Piergiorgio Messa"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191877","@type":"Researcher","foaf:name":[{"@value":"Daniel W. Coyne"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192005","@type":"Researcher","foaf:name":[{"@value":"Francesco Locatelli"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192004","@type":"Researcher","foaf:name":[{"@value":"Raphael M. Cohen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191876","@type":"Researcher","foaf:name":[{"@value":"Pieter Evenepoel"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192002","@type":"Researcher","foaf:name":[{"@value":"Sharon M. Moe"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192008","@type":"Researcher","foaf:name":[{"@value":"Albert Fournier"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192000","@type":"Researcher","foaf:name":[{"@value":"Johann Braun"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191872","@type":"Researcher","foaf:name":[{"@value":"Laura C. McCary"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192128","@type":"Researcher","foaf:name":[{"@value":"Valter J. Zani"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191873","@type":"Researcher","foaf:name":[{"@value":"Kurt A. Olson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388191874","@type":"Researcher","foaf:name":[{"@value":"Tilman B. Drüeke"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044388192007","@type":"Researcher","foaf:name":[{"@value":"William G. Goodman"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00284793"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00257850"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2004-04-08","prism:volume":"350","prism:number":"15","prism:startingPage":"1516","prism:endingPage":"1525"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa031633"}],"createdAt":"2004-04-07","modifiedAt":"2021-06-15","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050589286382788608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1050845764037278848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A new target region for changing the substrate specificity of amine transaminases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283695105256320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent Changes in Therapeutic Approaches and Association with Outcomes among Patients with Secondary Hyperparathyroidism on Chronic Hemodialysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710436313600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617774228736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Old and New Drugs for the Management of Bone Disorders in CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183691313792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204338398592","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A bone-kidney axis: New concept"},{"@language":"ja","@value":"注目すべき新機軸―Ｂｏｎｅ‐Ｋｉｄｎｅｙ　ａｘｉｓ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204678573312","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The mechanism of upper-gastrointestinal complication after taking cinacalcet hydrochloride"},{"@language":"ja","@value":"シナカルセト塩酸塩の上部消化管合併症の機序"},{"@language":"ja-Kana","@value":"シナカルセト エンサンエン ノ ジョウブ ショウカカン ガッペイショウ ノ キジョ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204680493952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of cinacalcet on magnesium and potassium metabolism in peritoneal dialysis patients with residual renal function"},{"@language":"ja","@value":"残腎機能を有する腹膜透析患者に対するシナカルセト投与時のＭｇ，Ｋ代謝に及ぼす影響"},{"@language":"ja-Kana","@value":"ザンジンキノウ オ ユウスル フクマク トウセキ カンジャ ニ タイスル シナカルセト トウヨジ ノ Mg K タイシャ ニ オヨボス エイキョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204680502784","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Survey of adverse events during treatment with cinacalcet hydrochloride in dialysis patients with secondary hyperparathyroidism"},{"@language":"ja","@value":"透析患者の二次性副甲状腺機能亢進症に対するシナカルセト塩酸塩投与時の副作用発現状況の調査"},{"@language":"ja-Kana","@value":"トウセキ カンジャ ノ 2ジセイ フクコウジョウセン キノウ コウシンショウ ニ タイスル シナカルセト エンサンエン トウヨジ ノ フクサヨウ ハツゲン ジョウキョウ ノ チョウサ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204871827200","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205177507200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics"},{"@value":"The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics"},{"@language":"ja-Kana","@value":"Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics"},{"@value":"Functional proteins involved in regulation of extracellular Ca2+ for drug development"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679656701056","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Management of calcium by oral vitamin D analogs during calcimimetics therapy for secondary hyperparathyroidism"},{"@language":"ja","@value":"二次性副甲状腺機能亢進症に対するシナカルセト治療―経口ビタミンＤ製剤併用による血清カルシウム調節―"},{"@language":"ja-Kana","@value":"2ジセイ フクコウジョウセン キノウ コウシンショウ ニ タイスル シナカルセト チリョウ ケイコウ ビタミン D セイザイ ヘイヨウ ニ ヨル ケッセイ カルシウム チョウセツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681275968896","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Surgical Approach in Hereditary Hyperparathyroidism"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681417254912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"医学と医療の最前線　　Ｃａｌｃｉｕｍ　Ｓｅｎｓｉｎｇ　Ｒｅｃｅｐｔｏｒ　（ＣａＲ）　Ａｇｏｎｉｓｔ"},{"@language":"ja-Kana","@value":"イガク ト イリョウ ノ サイゼンセン Calcium Sensing Receptor CaR Agonist"},{"@language":"en","@value":"[Calcium sensing receptor (CaR) agonist]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390307746617282176","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"カルシミメティクスとCKD‒MBD関連薬の処方実態調査"},{"@language":"en","@value":"Prescription Patterns of Calcimimetics and CKD‒MBD‒related Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564227330647936","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prescription change from cinacalcet hydrochloride to evocalcet―simultaneous switching of 147 chronic hemodialysis patients―"},{"@language":"ja","@value":"シナカルセト塩酸塩からエボカルセトへの処方変更―維持血液透析患者147人の一斉切り替え―"},{"@language":"ja-Kana","@value":"シナカルセト エンサンエン カラ エボカルセト エ ノ ショホウ ヘンコウ : イジ ケツエキ トウセキ カンジャ 147ニン ノ イッセイ キリカエ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238049535488","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"CKD-MBDとは ; 概念の構築と変遷"},{"@language":"ja-Kana","@value":"CKD-MBD トワ : ガイネン ノ コウチク ト ヘンセン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238049926656","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"CKD-MBD治療 (1) ; ビタミンD製剤とカルシウム感知受容体作動薬"},{"@value":"ビタミンD製剤とカルシウム感知受容体作動薬"},{"@language":"ja-Kana","@value":"ビタミン D セイザイ ト カルシウム カンチ ジュヨウタイ サドウヤク"}]},{"@id":"https://cir.nii.ac.jp/crid/1391412881285841536","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A study of switching from cinacalcet to evocalcet in maintenance hemodialysis patients"},{"@language":"ja","@value":"維持血液透析患者におけるシナカルセトからエボカルセトへの切り替えの検討"},{"@language":"ja-Kana","@value":"イジ ケツエキ トウセキ カンジャ ニ オケル シナカルセト カラ エボカルセト エ ノ キリカエ ノ ケントウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572360555035520","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"二次性副甲状腺機能亢進症に対する選択的副甲状腺PElT後の後療法についての検討:maxacalcitol静注パルス療法とcalcitriol経口パルス療法の比較"},{"@language":"ja-Kana","@value":"2ジセイ フクコウジョウセン キノウ コウシンショウ ニ タイスル センタクテキ フクコウジョウセン PElT ゴ ノ アト リョウホウ ニ ツイテ ノ ケントウ maxacalcitol ジョウチュウ パルス リョウホウ ト calcitriol ケイコウ パルス リョウホウ ノ ヒカク"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750477189632","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Threshold value of serum 25-hydroxyvitamin D concentration in relation to elevated serum parathyroid hormone concentrations in elderly Japanese women"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980075314125568","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regulation of parathyroid function in chronic renal failure"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892108622336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum alkaline phosphatase and infection-related mortality in hemodialysis patients : ten-year outcomes of the Q-cohort study"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa031633"},{"@type":"CIA","@value":"30022560115"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.47.1051_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.43.309_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.2215/cjn.12941213_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.51.631_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1111/1744-9987.12772_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1254/jphs.fmj04007x6_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.44.1007_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.3165/jjpn.23.189_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.42.857_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1007/s00223-020-00788-y_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1007/s00774-024-01500-y_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1038/srep10753_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1507/endocrj.k09e-204_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.42.931_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.51.681_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.54.21_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1007/s10157-022-02255-4_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.59.107_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.1053/j.ajkd.2011.12.034_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"},{"@type":"CROSSREF","@value":"10.4009/jsdt.52.585_references_DOI_COc5WZJWCMhSMXD0EODMhF6X3WT"}]}